(function(){ var content_array=["
关于济民可信集团<\/strong><\/p> \n 济民可信集团创建于1999年,总部位于中国南昌,主要产品管线为肾病、肿瘤、心脑血管、呼吸抗感染、疼痛五大领域,致力于为患者提供高质量的药品和创新医药解决方案。作为中国领先的大型现代制药集团之一,济民可信集团已连续多年位列中国医药工业百强前十。<\/p> \n 参考文献<\/strong><\/p> \n [1] Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China<\/span>: a national cross-sectional study[J]. Lancet, 2019, 394(10196): 407-418. <\/sup> <\/p> \n
[2] Moore WC, Bleecker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program[J]. J Allergy Clin Immunol, 2007,119(2):405-413.<\/sup><\/p> \n